IDH2 and glioblastoma: The C1 subtype of glioblastoma with IDH mutation, meanwhile, has a favorable survival outcome versus C2 subtype (Log-rank test, P = 1.2e-3) or glioblastoma without IDH mutation (Log-rank test, P = 1.3e-6).